Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+8.16%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$23.2B
AUM Growth
+$1.79B
(+8.3%)
Cap. Flow
+$478M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
23.34%
Holding
1,754
New
402
Increased
609
Reduced
482
Closed
253
Top Buys
| 1 |
Manulife Financial
MFC
|
+$133M |
| 2 |
Canadian Imperial Bank of Commerce
CM
|
+$120M |
| 3 |
Scotiabank
BNS
|
+$89.9M |
| 4 |
CSX Corp
CSX
|
+$88.7M |
| 5 |
Cenovus Energy
CVE
|
+$83.6M |
Top Sells
| 1 |
Walt Disney
DIS
|
+$149M |
| 2 |
Merck
MRK
|
+$130M |
| 3 |
Toronto Dominion Bank
TD
|
+$106M |
| 4 |
Shopify
SHOP
|
+$80.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$79.2M |
Sector Composition
| 1 | Technology | 22.59% |
| 2 | Financials | 21.5% |
| 3 | Industrials | 12.21% |
| 4 | Energy | 10.78% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Ryman Hospitality Properties
RHP
$6.35B
| $662K | ﹤0.01% |
+5,729
| New | +$662K |
|
1027
Eagle Bancorp
EGBN
$624M
| $661K | ﹤0.01% |
28,119
-18,852
| -40% | -$443K |
|
1028
Primis Financial Corp
FRST
$270M
| $658K | ﹤0.01% |
54,081
+9,670
| +22% | +$118K |
|
1029
Valero Energy
VLO
$49B
| $653K | ﹤0.01% |
3,828
-166,207
| -98% | -$28.4M |
|
1030
Donnelley Financial Solutions
DFIN
$1.54B
| $652K | ﹤0.01% |
10,518
+2,269
| +28% | +$141K |
|
1031
Argan
AGX
$3.21B
| $649K | ﹤0.01% |
12,846
+3,189
| +33% | +$161K |
|
1032
Kellanova
K
$27.7B
| $649K | ﹤0.01% |
11,328
+1,986
| +21% | +$114K |
|
1033
Toyota
TM
$258B
| $642K | ﹤0.01% |
+2,550
| New | +$642K |
|
1034
Spectrum Brands
SPB
$1.33B
| $641K | ﹤0.01% |
7,206
-58,923
| -89% | -$5.24M |
|
1035
Cato Corp
CATO
$90M
| $641K | ﹤0.01% |
111,105
+30,725
| +38% | +$177K |
|
1036
Sherwin-Williams
SHW
$91.9B
| $641K | ﹤0.01% |
1,845
-864
| -32% | -$300K |
|
1037
Humana
HUM
$33.5B
| $640K | ﹤0.01% |
1,847
+859
| +87% | +$298K |
|
1038
China Yuchai International
CYD
$1.42B
| $631K | ﹤0.01% |
73,970
+2,445
| +3% | +$20.9K |
|
1039
PLDT
PHI
$4.24B
| $630K | ﹤0.01% |
25,549
+9,800
| +62% | +$242K |
|
1040
XBiotech
XBIT
$86M
| $629K | ﹤0.01% |
77,413
+13,468
| +21% | +$109K |
|
1041
Trustmark
TRMK
$2.44B
| $629K | ﹤0.01% |
22,369
-17,585
| -44% | -$494K |
|
1042
BOK Financial
BOKF
$7.08B
| $625K | ﹤0.01% |
+6,791
| New | +$625K |
|
1043
Douglas Elliman
DOUG
$240M
| $624K | ﹤0.01% |
395,079
+49,611
| +14% | +$78.4K |
|
1044
Schlumberger
SLB
$53.8B
| $624K | ﹤0.01% |
11,387
-2,769
| -20% | -$152K |
|
|
YRD
1045
Yiren Digital
YRD
$518M
| $623K | ﹤0.01% |
138,131
+39,905
| +41% | +$180K |
|
1046
Cullinan Oncology
CGEM
$391M
| $620K | ﹤0.01% |
+36,401
| New | +$620K |
|
1047
Kimberly-Clark
KMB
$43B
| $615K | ﹤0.01% |
4,757
+1,551
| +48% | +$201K |
|
1048
Greif
GEF
$3.6B
| $612K | ﹤0.01% |
+8,865
| New | +$612K |
|
1049
Harvard Bioscience
HBIO
$19.7M
| $611K | ﹤0.01% |
144,055
+2,566
| +2% | +$10.9K |
|
1050
Mercado Libre
MELI
$119B
| $605K | ﹤0.01% |
+400
| New | +$605K |
|